Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1GSK3AGSK3BHRH1HRH2HTR7IDH1IDH2IMPA1IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CA4 | P22748 | 2/20 | 0.58 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.37 |
| ▸ | ACLY | P53396 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL73101 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL2235362 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL9125740 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL150577 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL3388434 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL2544645 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL8806048 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL11131940 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL11882611 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL2345211 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CA4HMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021061066-A1 | EFFERVESCENT FORMULATIONS OF SAPROPTERIN DIHYDROCHLORIDE | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2021-04-01 | — | — | WO | claimed |
| EP-2870961-B1 | Effervescent formulations of pramipexole | SANOVEL ILAC SANAYI VE TICARET AS (TR) | 2018-07-18 | — | — | EP | claimed |
| EP-2870961-A1 | Effervescent formulations of pramipexole | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2015-05-13 | — | — | EP | claimed |
| EP-4376973-A1 | MOLECULAR IMPRINTED POLYMER AND USE THEREOF IN QUANTIFYING A PESTICIDE IN A SAMPLE | Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (FR) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023006895-A1 | MOLECULAR IMPRINTED POLYMER AND USE THEREOF IN QUANTIFYING A PESTICIDE IN A SAMPLE | ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS (FR) | 2023-02-02 | — | — | WO | disclosed |
| WO-2021061066-A1 | EFFERVESCENT FORMULATIONS OF SAPROPTERIN DIHYDROCHLORIDE | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2021-04-01 | — | — | WO | disclosed |
| EP-2870961-B1 | Effervescent formulations of pramipexole | SANOVEL ILAC SANAYI VE TICARET AS (TR) | 2018-07-18 | — | — | EP | disclosed |
| EP-3212234-A1 | PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN AND PPAR AGONISTS | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2017-09-06 | — | — | EP | disclosed |
| EP-3212185-A1 | PHARMACEUTICAL COMBINATIONS OF VILDAGLIPTIN AND PPAR AGONISTS | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016066668-A1 | PHARMACEUTICAL COMBINATIONS OF VILDAGLIPTIN AND PPAR AGONISTS | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2016-05-06 | — | — | WO | disclosed |
| WO-2016066666-A1 | PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN AND PPAR AGONISTS | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2016-05-06 | — | — | WO | disclosed |
| EP-2870961-A1 | Effervescent formulations of pramipexole | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2015-05-13 | — | — | EP | disclosed |
| US-4824664-A | ANTIHISTAMINES | LABORATOIRES SMITH KLINE & FRENCH (FR) | 1989-04-25 | — | — | US | disclosed |